Clinical research: Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors
Collecting data from 4438 #Cancer patients, the @RequiteProject aims to identify biomarkers for radiotherapy toxicity to improve quality of life.
VHIO's involvement led by @SaraGutierrezEn and Radiation Oncology Department from @vallhebron.
Read more: https://t.co/cV09ZVZUm0
Were you involved in the #REQUITE study on radiotherapy @Leic_hospital? A new patient leaflet to say thanks & update you on the progress of the study is available here, in 7 languages https://t.co/J1KwxtMUYT
@RequiteProject@hopeagnstcancer
Final REQUITE Dissemination report available! The aim of this report is to provide a final update on the outputs and dissemination activities of the REQUITE consortium. Thanks to the whole consortium including a very active #PatientAdvisoryGroup. see https://t.co/gI3ucXv8Me
REQUITE Report on SNP selection online! To report on the genotyping undertaken of blood samples collected in the observational study and processed by the CIGMR biobank. see:https://t.co/P7CekJvjJg #SNPs#CNVs#RadiotherapyToxicity#PredictionModels.
REQUITE report on patient recruitment available online: https://t.co/wWrw3mLBon In total, 4,438 patients with breast, prostate or lung cancer were recruited prospectively. 383 additional lung cancer patients were genotyped alongside the REQUITE cohorts. (additional lung cohorts)
Chamberlain Mbah defended his PhD and had the manuscript accepted (September 2018): “Challenges in predicting normal tissue toxicity in radiotherapy”. https://t.co/cIjPWtbAVZ
We are very proud of Four PhD students who have successfully defended their theses that made use of REQUITE data: see: https://t.co/UMUGLoa6wC
Gilles Defraene, Tim Rattay, Kerstie Johnson and Chamberlain Mbah.
Kerstie Johnson defended her PhD and the manuscript accepted (July 2018): “Predicting radiotherapy toxicity in patients treated with radical radiotherapy using predictive assays and circadian rhythm”. https://t.co/e7DzofwE54
Tim Rattay defended his PhD and had the manuscript accepted (Febr2018): “Predicting acute radiation toxicity in breast cancer”. This thesis is not currently available. due to an embargo by the REQUITEconsortium that core publications are prioritised above other research/analyses.
Gilles Defraene defended his PhD and had the manuscript accepted (January 2018): “Image based quantification of radiation induced lung damage”. https://t.co/omHpsixaIh
❗APPLICATIONS FOR PHD PROJECTS ARE NOW OPEN❗ https://t.co/1nZFndxXK8
We have a wide range of clinical and non clinical opportunities that will train the science leaders of the future!
@RequiteProject animations highlight a #bettertogether approach to science and how to build cohorts to identify genetic variants that increase risk of radiotherapy toxicity. https://t.co/NhXKrJ5RGZ
https://t.co/k651Pdf1qw
Radiation Therapy after surgery can decrease the chance of cancer returning in the breast and improve survival. Check out our video on Radiation Therapy for #BreastCancer to learn more about this treatment method. #bcsm#breastcancerawareness#radonc https://t.co/ARlKuJsXVX